The effectiveness of probiotics in eradicating Helicobacter pylori infection of the stomach

Phase 3

• Conditions: Helicobacter pylori infection in dyspeptic patients.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20221216056834N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

age between 15-40 years
Verbal and written consent
symptoms of dyspepsia
Positive fecal Helicobacter pylori antigen test.

Exclusion Criteria

use of any antibiotic in the last 2 weeks
consumption of pump inhibitor during the last 1 month
History of any proven malignancy
history of receiving Helicobacter pylori eradication regimen at any time in the past.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fecal antigen. Timepoint: one month after the end of the intervention. Method of measurement: elisa test.

Secondary Outcome Measures

Name	Time	Method
Digestive complications. Timepoint: 1 month after the end of the intervention. Method of measurement: questionnaire.